5LHQ image
Deposition Date 2016-07-12
Release Date 2017-06-28
Last Version Date 2024-10-23
Entry Detail
PDB ID:
5LHQ
Title:
The EGR-cmk active site inhibited catalytic domain of murine urokinase-type plasminogen activator in complex with the allosteric inhibitory nanobody Nb7
Biological Source:
Source Organism:
Mus musculus (Taxon ID: 10090)
Vicugna pacos (Taxon ID: 30538)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.21
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 31 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Urokinase-type plasminogen activator
Gene (Uniprot):Plau
Mutations:C122A
Chain IDs:A
Chain Length:247
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:Camelid-Derived Antibody Fragment Nb7
Chain IDs:B
Chain Length:152
Number of Molecules:1
Biological Source:Vicugna pacos
Peptide-like Molecules
PRD_000288
Primary Citation
Discovery of a novel conformational equilibrium in urokinase-type plasminogen activator.
Sci Rep 7 3385 3385 (2017)
PMID: 28611361 DOI: 10.1038/s41598-017-03457-7

Abstact

Although trypsin-like serine proteases have flexible surface-exposed loops and are known to adopt higher and lower activity conformations, structural determinants for the different conformations have remained largely obscure. The trypsin-like serine protease, urokinase-type plasminogen activator (uPA), is central in tissue remodeling processes and also strongly implicated in tumor metastasis. We solved five X-ray crystal structures of murine uPA (muPA) in the absence and presence of allosteric molecules and/or substrate-like molecules. The structure of unbound muPA revealed an unsuspected non-chymotrypsin-like protease conformation in which two β-strands in the core of the protease domain undergoes a major antiparallel-to-parallel conformational transition. We next isolated two anti-muPA nanobodies; an active-site binding nanobody and an allosteric nanobody. Crystal structures of the muPA:nanobody complexes and hydrogen-deuterium exchange mass spectrometry revealed molecular insights about molecular factors controlling the antiparallel-to-parallel equilibrium in muPA. Together with muPA activity assays, the data provide valuable insights into regulatory mechanisms and conformational flexibility of uPA and trypsin-like serine proteases in general.

Legend

Protein

Chemical

Disease

Primary Citation of related structures